Tomoko Inoue

No ORCID on file · 5 papers in corpus
case-report 2022
·doi:10.5180/jsgoe.38.1_170

Inguinal endometriosis is rare and accounts for 0.3% to 0.6% of all cases of endometriosis. Although a few studies have described drug therapy for this condition, inguinal endometriosis is primarily treated surgically. We report a case of i…

other 2022
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC ·doi:10.1016/j.jogc.2022.10.014
other 2022
Reproductive medicine and biology ·doi:10.1002/rmb2.12448

PURPOSE: Relugolix is an oral gonadotropin-releasing hormone antagonist (GnRHant), which was first introduced in 2019. This study investigated the effects of the conventional injectable GnRHant formulation and this new oral GnRHant formulat…

other 2015
Reproductive medicine and biology ·doi:10.1007/s12522-014-0198-9

PURPOSE: The aim of this study was to determine the prophylactic effects of cabergoline on ovarian hyperstimulation syndrome (OHSS) after oocyte retrieval. METHODS: A total of 187 women underwent controlled ovarian stimulation using gonado…

case-report 2014
BMC women's health ·doi:10.1186/1472-6874-14-82

BACKGROUND: Xanthogranulomatous inflammation is an uncommon form of chronic inflammation that is destructive to the normal tissue of affected organs. Although xanthogranulomatous endometritis and xanthogranulomatous salpingitis of the femal…